Perspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines

Clinical Microbiology Reviews - United States
doi 10.1128/cmr.00005-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Perspectives for Developing New Tuberculosis Vaccines Derived From the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2013English

Preclinical Trial Success With New Influenza Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2006English

Prospects for New Vaccines Against Tuberculosis

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2002English

Zika Virus Vaccines: Challenges and Perspectives

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2018English

Clinical Development of New TB Vaccines: Recent Advances and Next Steps

Frontiers in Microbiology
Microbiology
2020English

Reasons for Optimism in the Search for New Vaccines for Tuberculosis

Epidemiology and Infection
EpidemiologyInfectious Diseases
2017English

Editorial: Clinical Psychometrics: Old Issues and New Perspectives

Frontiers in Psychology
Psychology
2019English

Role of Fused Mycobacterium Tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines

Frontiers in Immunology
AllergyImmunology
2014English

4. Clinical Perspectives of New Antiplatelet Drugs

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy